Iqvia Holdings Financial Diagnostics

The current investor indifference towards the small price fluctuations of Iqvia Holdings has created some momentum for investors as it was traded today as low as 0.0 and as high as 0.0 per share. The company directors and management did not add any value to Iqvia Holdings investors in October. However, most investors can still diversify their portfolios with Iqvia Holdings to hedge your portfolio against high-volatility market scenarios. The stock standard deviation of daily returns for 30 days (very short) investing horizon is currently 0.0. The very small Stock volatility is a good signal to investors with longer term investment horizons. This diagnostics interface makes it easy to digest most current publicly released information about Iqvia Holdings as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis Iqvia Holdings price relationship with some important fundamental indicators such as market cap and management efficiency. See also Your Equity Center.

Iqvia Holdings Note

About 91.0% of the company shares are owned by institutional investors. The book value of Iqvia Holdings was at this time reported as 30.74. The company has Price/Earnings To Growth (PEG) ratio of 1.6. Iqvia Holdings last dividend was issued on February 16, 2011. The entity had 2:1 split on May 25, 1999. Quintiles IMS Holdings, Inc. offer biopharmaceutical development services and commercial outsourcing services in the Americas, Europe, Africa, and the AsiaPacific. To find out more about QWEST COMM INTL I contact Thomas Pike at 919-998-2000 or learn more at www.quintiles.com.

Iqvia Holdings Alerts

Iqvia Holdings is not yet fully synchronised with the market data
Iqvia Holdings has some characteristics of a very speculative penny stock
Iqvia Holdings has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its interest payments
Over 91.0% of the company shares are owned by institutional investors

Iqvia Holdings Upcoming and Recent Events

Upcoming Quarterly Earning ReportMay 2, 2017
Next Earnings ReportJuly 26, 2017
Next Fiscal Quarter EndMarch 31, 2017
Next Fiscal Year EndFebruary 13, 2018
Last Quarter Report DateDecember 31, 2016
Last Earning Anouncement DateMarch 31, 2016

Iqvia Holdings SEC Filings

Financial Statements and Exhibits. Other Events
Financial Statements and Exhibits. Unclassified Corporate Event. Results of Operations and Financial Condition
Unclassified Corporate Event
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Financial Statements and Exhibits. Regulation FD Disclosure. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Financial Statements and Exhibits. Results of Operations and Financial Condition
Unclassified Corporate Event
Unclassified Corporate Event. Unclassified Corporate Event. Unclassified Corporate Event. Unclassified Corporate Event. Completion of Acquisition or Disposition of Assets

Market Capitalization

The company currently falls under 'Large-Cap' category with current capitalization of 21.87 B.

Profitablity

The company has Profit Margin of 0.7 % which indicates that it operates at a low profit margin and even small decline in sales will erase profits resulting in a net loss, or a negative margin. This is way below average. Similarly, it shows Operating Margin of 10.9 % which imply that for every $100 of sales it generated an operating income of 0.11.

Management Efficiency

Iqvia Holdings has return on total asset of 4.03 % which means that for every 100 dollars spent on asset it generated profit of $4.03. This is acceptable considering the industry classification. Similarly, it shows return on equity (ROE) of 1.89 % implying that it made 1.89 on every $100 invested by shareholders.

Stock Holders for Iqvia Holdings

Information
Ratio
Value
At Risk
Dow Jones U S Biotechnology In 0.09 (1.24) 
Nasdaq US Mid Cap Growth TR Ind 0.0259 (1.64) 
Nasdaq US Multi Cap Growth Tota(0.0029) (2.17) 
NASDAQ N America Large Mid Cap(0.06) (2.22) 
NQ US Biotech Large Mid Cap GB 0.0001 (2.19) 
Nasdaq EM Plus Korea Small Cap(0.08) (2.90) 
AB Cap Fund Inc AB Concentr(0.0306) (1.97) 
SPDR SP 500 Buyback ETF 0.06 (2.19) 
Schwab Fundamental US Small Com 0.0138 (1.84) 
Neuberger Berman Focus Assets 0.026 (1.55) 
Janus Henderson Enterprise Fund(0.0447) (2.18) 
Janus Henderson Enterprise Fund(0.05) (2.17) 

Iqvia Holdings Technical and Predictive Indicators

Did you try this?

Run Bollinger Bands Now

   

Bollinger Bands

Use Bollinger Bands indicator to analyze target price for a given investing horizon
All  Next Launch Module
See also Your Equity Center. Please also try Fund Screener module to find activelly-traded funds from around the world traded on over 30 global exchanges.
Search macroaxis.com